Joshua B. Basinger, Esq., CTFA
Joshua B. Basinger, Esq., CTFA Promoted to Manager of Trust Services, Senior Trust Officer, Principal at Johnson Investment Counsel
Johnson Investment Counsel proudly welcomes Joshua B. Basinger, Esq., CTFA as a new shareholder. Since joining the firm in 2017, Josh has made significant contributions to its growth and success. He holds both a J.D. and the Certified Trust and Financial Advisor (CTFA) designation. Johnson Investment Counsel serves clients in 50 states, with 6 offices across Ohio and Michigan.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
7 hours ago
- Associated Press
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Capricor between October 9, 2024 and July 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 13, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. ('Capricor' or the 'Company') (NASDAQ: CAPR) and reminds investors of the September 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that defendants provided investors with material information concerning Capricor's lead cell therapy candidate drug deramiocel for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD). Defendants' statements included, among other things, Capricor's ability to obtain a Biologics License Application (BLA) for deramiocel from the U.S. Food and Drug Administration (FDA). Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning its four-year safety and efficacy data from its Phase 2 HOPE-2 trial study of deramiocel. On July 11, 2025, Capricor issued a press release announcing it received a Complete Response Letter (CRL) from the FDA denying the BLA specifically citing it did not meet the statutory requirement for substantial evidence of effectiveness and the need for additional clinical data. Further, the CRL referenced outstanding items in the Chemistry, Manufacturing, and Controls section of the application. Following this news, the price of Capricor stock declined from $11.40 per share on July 10, 2025 to $7.64 per share on July 11, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Capricor's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Capricor Therapeutics class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit
CBS News
21 hours ago
- CBS News
California could save $225 million yearly by ditching return-to-office mandate, audit Finds
A new audit found that the State of California could save $225 million a year by not enforcing return-to-office orders for state workers. The audit comes amid the saga for state workers and the political debate between remote versus in-person work. It found that Gov. Gavin Newsom's office "did not gather some important information about space needs and costs" before ordering employees back to the office four days a week. Assemblymember Josh Hoover requested the audit and said the findings dispute Newsom's calls for a one-size-fits-all hybrid work order. "One of the big problems is that the governor's office was not prepared for a return-to-work order," Hoover said. "I really don't think this should be a partisan issue. I think we should be doing what makes the most sense from a policy standpoint." The audit also showed that some state departments don't have the space for all their employees to return to the office four days a week after ending office leases during the pandemic. The audit shows the Department of Health Care Services would need 541 more workspaces, and the Department of Resources, Recycling and Recovery needs 123 more workspaces. "He told state agencies you need to prepare for telework and implement telework, and that led to decisions where in some cases they're not set up to get employees back," Hoover said. Newsom's office issued a response disagreeing with the study, saying: "This audit on state telework is not a scientific study, nor does it paint a complete picture of the state workforce or the benefits of working in person. While we appreciate the auditor's time in collecting this information, we respectfully disagree with the auditor's findings, which are based on estimates and, as noted throughout the audit, hypothetical theories and incomplete information. However, we will take their recommendations into account as we move forward with managing the state workforce and facilities." State worker unions have protested the governor's four-day return to office orders, which are currently set to take effect in July 2026. Now, this audit is adding to the dispute. "For me, it has been a reminder that we cannot rest," Neto said. The audit recommends that the state legislature jump into this debate and create laws requiring every state department to decide which positions should be remote and in person. Assemblymember Hoover said that he hopes to introduce that legislation next year.
E&E News
a day ago
- E&E News
Service cuts planned at two large Pennsylvania transit agencies
Pennsylvania's largest mass transit systems are facing service cuts as Republican state lawmakers and Democratic Gov. Josh Shapiro remain deadlocked in overtime budget negotiations. If no funding deal is reached by Thursday, the Southeastern Pennsylvania Transportation Authority, which serves the Philadelphia area, plans to hike fares and cut service this month — moves it calls 'the point of no return.' Pittsburgh Regional Transit officials have approved plans to cut service next year unless the state boosts transit funding. Transit funding is one of the biggest sticking points holding up Pennsylvania's budget, which was due to be approved by June 30. The problem is especially acute in the Philadelphia region, with SEPTA facing a $213 million deficit. Advertisement 'We are past the point of short-term, stop-gap measures. We are past the point of a few months of fixes,' Shapiro said Sunday at SEPTA headquarters in Philadelphia's Center City. 'It is time to have recurring, long term revenue for SEPTA and for the other mass transit agencies across Pennsylvania.'
